Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Roach

Showing results (281-290 of 291) with videos related to

Pageof 30
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 15, 2020
Targeted inhibition of gut bacterial β-glucuronidase activity enhances anticancer drug efficacyAadra P Bhatt, Samuel J Pellock, Kristen A Biernat, et al.
International Journal of Radiation Oncology, Biology, Physics|October 20, 2001
Radiation Therapy Oncology Group. Research Plan 2002-2006. Genitourinary Cancer CommitteeH Sandler, W U Shipley, L Gomella, et al.
Physical Review Letters|January 22, 2002
L-H transition in the mega-amp spherical tokamakR J Akers, G F Counsell, A Sykes, et al.
International Journal of Radiation Oncology, Biology, Physics|October 20, 2001
Radiation Therapy Oncology Group. Research Plan 2002-2006. Image-Guided Radiation Therapy CommitteeJ Michalski, J A Purdy, L Gaspar, et al.
Clinical & Translational Immunology|June 18, 2021
Next-generation Bruton's tyrosine kinase inhibitor BIIB091 selectively and potently inhibits B cell and Fc receptor signaling and downstream functions in B cells and myeloid cellsEris Bame, Hao Tang, Jeremy C Burns, et al.
Journal of Medicinal Chemistry|November 4, 2021
Discovery and Preclinical Characterization of BIIB091, a Reversible, Selective BTK Inhibitor for the Treatment of Multiple SclerosisBrian T Hopkins, Eris Bame, Bekim Bajrami, et al.
Journal of Medicinal Chemistry|July 12, 2021
Harnessing the Role of HDAC6 in Idiopathic Pulmonary Fibrosis: Design, Synthesis, Structural Analysis, and Biological Evaluation of Potent InhibitorsGiuseppe Campiani, Caterina Cavella, Jeremy D Osko, et al.
Cellular and Molecular Gastroenterology and Hepatology|October 20, 2025
An Epigenetic Basis for Sustained Inflammatory Epithelial Progenitor Cell States in Crohn's DiseaseTatiana A Karakasheva, Clara Morral Martinez, Yusen Zhou, et al.
The Lancet. Respiratory Medicine|August 19, 2022
Longitudinal lung function and gas transfer in individuals with idiopathic pulmonary fibrosis: a genome-wide association studyRichard J Allen, Justin M Oldham, David A Jenkins, et al.
Journal of Pediatric Gastroenterology and Nutrition|October 30, 2012
Research progress reported at the 50th Anniversary of the Discovery of Congenital Sucrase-Isomaltase Deficiency WorkshopMark Gilger, Bruce Hamaker, Buford L Nichols, et al.
Pageof 30

Showing results (281-290 of 291) with videos related to

Sort By:
Pageof 30
Proceedings of the National Academy of Sciences of the United States of America|March 15, 2020
Targeted inhibition of gut bacterial β-glucuronidase activity enhances anticancer drug efficacyAadra P Bhatt, Samuel J Pellock, Kristen A Biernat, et al.
International Journal of Radiation Oncology, Biology, Physics|October 20, 2001
Radiation Therapy Oncology Group. Research Plan 2002-2006. Genitourinary Cancer CommitteeH Sandler, W U Shipley, L Gomella, et al.
Physical Review Letters|January 22, 2002
L-H transition in the mega-amp spherical tokamakR J Akers, G F Counsell, A Sykes, et al.
International Journal of Radiation Oncology, Biology, Physics|October 20, 2001
Radiation Therapy Oncology Group. Research Plan 2002-2006. Image-Guided Radiation Therapy CommitteeJ Michalski, J A Purdy, L Gaspar, et al.
Clinical & Translational Immunology|June 18, 2021
Next-generation Bruton's tyrosine kinase inhibitor BIIB091 selectively and potently inhibits B cell and Fc receptor signaling and downstream functions in B cells and myeloid cellsEris Bame, Hao Tang, Jeremy C Burns, et al.
Journal of Medicinal Chemistry|November 4, 2021
Discovery and Preclinical Characterization of BIIB091, a Reversible, Selective BTK Inhibitor for the Treatment of Multiple SclerosisBrian T Hopkins, Eris Bame, Bekim Bajrami, et al.
Journal of Medicinal Chemistry|July 12, 2021
Harnessing the Role of HDAC6 in Idiopathic Pulmonary Fibrosis: Design, Synthesis, Structural Analysis, and Biological Evaluation of Potent InhibitorsGiuseppe Campiani, Caterina Cavella, Jeremy D Osko, et al.
Cellular and Molecular Gastroenterology and Hepatology|October 20, 2025
An Epigenetic Basis for Sustained Inflammatory Epithelial Progenitor Cell States in Crohn's DiseaseTatiana A Karakasheva, Clara Morral Martinez, Yusen Zhou, et al.
The Lancet. Respiratory Medicine|August 19, 2022
Longitudinal lung function and gas transfer in individuals with idiopathic pulmonary fibrosis: a genome-wide association studyRichard J Allen, Justin M Oldham, David A Jenkins, et al.
Journal of Pediatric Gastroenterology and Nutrition|October 30, 2012
Research progress reported at the 50th Anniversary of the Discovery of Congenital Sucrase-Isomaltase Deficiency WorkshopMark Gilger, Bruce Hamaker, Buford L Nichols, et al.
Pageof 30